Brief: Genetrix Life Sciences A.B. exempted from bidding for Sygnis AG
March 10 (Reuters) - Genetrix Life Sciences A.B.:
* Genetrix Life Sciences A.B. and Genetrix S.L. received
exemption from obligation to submit mandatory takeover offer for
Sygnis AG LIO1k.DE
Source text for Eikon: ID:nEQ9SKxQ3a
Further company coverage: LIO1k.F
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on 2Invest AG
See all newsBrief: sygnis Q1 revenues up 19 pct to 76,000 euros
Brief: Sygnis signs non-exclusive distribution agreement with Cambridge Bioscience Ltd
Brief: Sygnis FY 2014 operating loss reduced to 3.2 mln euros
Brief: Sygnis announces global launch of SunScript Reverse Transcriptase
Brief: Sygnis signs non-exclusive distribution agreement with Sopachem